Selective reserpine-resistant accumulation of catecholamines in central dopamine neurones after DOPA administration.

The capacity of central monoamine neurones to form and store catecholamines (CA), following administration of DOPA, has been investigated in reserpine pretreated rats. Fluorescence histochemistry showed that there occur selective accumulations of CA in previously known dopamine (DA) nerve terminals following treatment with DOPA together with a peripheral decar☐ylase inhibitor (Ro4-4602, MK-486) of reserpine pretreated rats. These DA accumulations were readily depleted amphetamine and associated with the apperance of marked stereotyped behaviour.In vitro experiments with [3H]noradrenaline ([3H]NA) revealed that with a concentration of10−5M but not with 10−7M selective accumulation of [3H]NA occurs in homogenates of neostriatum from reserpine treated animals. The monoamine oxidase (MAO) activity in the neostriatum and the neocortex was not affected by reserpine pretreatment. It is suggested that the selective accumulation of CA in the DA nerve terminals in the presence of high amine concentrations could be the result of a reserpine-resistant binding of CA to the DA granules, a binding which could partly protect the store from the action of MAO. This discovery has made it possible to further characterize and trace DA terminals. Evidence has been obtained that new types of presumaby DA nerve terminals may exist in the limbic cortex, particularly in the cingulate cortex, and also in certain parts of the neocortex (frontal cortex). In addition, some of the CA terminals in the septal area may be DA nerve terminals. New types of nerve cell bodies lacking endogenous monoamine fluorescence have been mapped out in the brain, particularly in the hypothalamus and the preoptic area which can take up and decar☐ylate DOPA. These cells may contain a monommine-like compound.

[1]  G. Thieme,et al.  FLUORESCENCE OF CATECHOL AMINES AND RELATED COMPOUNDS CONDENSED WITH FORMALDEHYDE , 1962 .

[2]  J. Glowinski,et al.  Some evidence for the existence of dopaminergic neurons in the rat cortex. , 1973, Brain research.

[3]  W. Burkard,et al.  Increase of Cerebral Catecholamines caused by 3,4-Dihydroxyphenylalanine after Inhibition of Peripheral Decarboxylase , 1967, Nature.

[4]  C. Sachs,et al.  DEGENERATION OF CENTRAL AND PERIPHERAL NORADRENALINE NEURONS PRODUCED BY 6‐HYDROXY‐DOPA , 1972, Journal of neurochemistry.

[5]  L. Olson,et al.  Extraneuronal binding of catecholamines and 3,4-dihydroxyphenylalanine (dopa) in salivary glands. , 1967, Acta physiologica Scandinavica.

[6]  W. Lichtensteiger,et al.  Uptake of exogenous catecholamines by monoamine-containing neurons of the central nervous system: uptake of catecholamines by arcuato-infundibular neurons. , 1966, The Journal of pharmacology and experimental therapeutics.

[7]  T. Hökfelt,et al.  Fluorescence Microscopy in Neuroanatomy , 1970 .

[8]  A. Pletscher,et al.  Dopa‐induced locomotor stimulation after inhibition of extracerebral decarboxylase , 1969, The Journal of pharmacy and pharmacology.

[9]  Lars Olson,et al.  Ascending Monoamine Neurons to the Telencephalon and Diencephalon , 1966 .

[10]  K. Fuxe,et al.  Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. , 1966, Acta physiologica Scandinavica.

[11]  A. Weindl,et al.  Brain-endocrine interaction , 1972 .

[12]  C. Sachs,et al.  Synthesis of noradrenaline from 3,4-dihydroxyphenylalanine (DOPA) and dopamine in adrenergic nerves of mouse atrium--effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition. , 1970, Acta physiologica Scandinavica.

[13]  K. Fuxe,et al.  Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition. , 1972, Brain research.

[14]  C J CLEMEDSON,et al.  DYNAMIC RESPONSE OF CHEST WALL AND LUNG INJURIES IN RABBITS EXPOSED TO AIR SHOCK WAVES OF SHORT DURATION. , 1964, Acta physiologica Scandinavica. Supplementum.

[15]  A. Randrup,et al.  Behavioural Stereotypies Induced by Pharmacological Agents , 1968 .

[16]  K. Fuxe,et al.  Antiparkinsonian drugs and central dopamine neurons. , 1970, Life sciences. Pt. 1: Physiology and pharmacology.

[17]  U. Ungerstedt,et al.  Monoamine fluorescence in CNS smears: sensitive and rapid visualization of nerve terminals without freeze-drying. , 1970, Brain research.

[18]  P. Lidbrink,et al.  SEMIQUANTITATIVE ESTIMATION OF FORMALDEHYDE-INDUCED FLUORESCENCE OF NORADRENALINE IN CENTRAL NORADRENALINE NERVE TERMINALS , 1971, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[19]  W. Lichtensteiger.  Katecholaminhaltige Neurone in der neuroendokrinen Steuerung Prinzip, Anwendung der Mikrofluorimetrie. , 1970, Progress in histochemistry and cytochemistry.

[20]  K. Fuxe,et al.  The effect of drugs on accumulation of monoamines in tubero-infundibular dopamine neurons , 1967 .

[21]  K. Fuxe,et al.  L‐Dopa induced changes in central monoamine neurons after peripheral decarboxylase inhibition * , 1970, The Journal of pharmacy and pharmacology.

[22]  K Fuxe,et al.  Pharmaco-histochemical evidence of the existence of dopamine nerve terminals in the limbic cortex. , 1974, European journal of pharmacology.

[23]  K. Fuxe,et al.  Cellular localization of monoamines in the area postrema of certain mammals , 1965, The Journal of comparative neurology.

[24]  S. Snyder,et al.  Regional differences in H3-norepinephrine and H3-dopamine uptake into rat brain homogenates. , 1969, The Journal of pharmacology and experimental therapeutics.

[25]  K. Fuxe,et al.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM. , 1965, Acta physiologica Scandinavica. Supplementum.

[26]  W. Lichtensteiger.  Uptake of Norepinephrine in Periglomerular Cells of the Olfactory Bulb of the Mouse , 1966, Nature.

[27]  G. Jonsson.  Quantitation of Biogenic Monoamines Demonstrated with the Formaldehyde Fluorescence Method , 1973 .

[28]  W. Lichtensteiger.  Monoamines in the subfornical organ. , 1967, Brain Research.

[29]  U. Ungerstedt,et al.  On the distribution and possible function of monamine nerve terminals in the olfactory bulb of the rabbit. , 1965, Life sciences.

[30]  K. Fuxe,et al.  Studies on the action of some psychoactive drugs on central noradrenaline neurons after inhibition of dopamine-beta-hydroxylase. , 1970, Brain research.

[31]  K. Fuxe,et al.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS. , 1964, Acta physiologica Scandinavica. Supplementum.

[32]  A. Björklund,et al.  Fluorescence histochemical and microspectrofluorometric mapping of dopamine and noradrenaline cell groups in the rat diencephalon. , 1973, Brain research.

[33]  G. Jonsson.  Quantitation of fluorescence of biogenic monoamines demonstrated with the formaldehyde flourescence method. , 1971, Progress in histochemistry and cytochemistry.

[34]  R. Wurtman,et al.  A SENSITIVE AND SPECIFIC ASSAY FOR THE ESTIMATION OF MONOAMINE OXIDASE. , 1963, Biochemical pharmacology.